MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202547097769 A) filed by Biontech Se; and The General Hospital Corporation, Mainz, Germany, on Oct. 10, for 'hiv vaccine.'
Inventor(s) include Le Douce, Valentin; Esaulova, Ekaterina; Kaxiras, Daphne; Rooney, Michael Steven; Addona, Theresa; Sahin, Ugur; and Gaiha, Gaurav.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "The present invention concerns compositions comprising an RNA molecule, wherein the RNA molecule comprises an expression cassette encoding an immunogenic peptide, which peptide comprises at least two fragments, wherein each fragment comprises at least one epitope, wherein the epitope is derived from an amino acid sequence encoded by the human immunodeficiency virus (HIV) and medical preparations comprising such compositions. Furthermore, the invention concerns methods for preventing or treating HIV."
The patent application was internationally filed on Apr. 12, 2024, under International application No.PCT/US2024/024503.
Disclaimer: Curated by HT Syndication.
